title: [Subcutaneous panniculitis-like T-cell lymphoma following treatment with rituximab and cyclophosphamide].
authors: Service de dermatologie, hôpitaux de Brabois, 6, rue du Morvan, 54511 Vandoeuvre-Lès-Nancy, France. jl.schmutz@chu-nancy.fr
authors: J-L
authors: JL
authors: Schmutz
authors: P
authors: P
authors: Trechot
mesh_terms: D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects; D002471:Cell Transformation, Neoplastic; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D015329:Gene Rearrangement, T-Lymphocyte; D006801:Humans; D016130:Immunophenotyping; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000473:pathology; D015434:Panniculitis / Q000175:diagnosis; D000069283:Rituximab; D040521:Subcutaneous Tissue; D013601:T-Lymphocytes / Q000473:pathology; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D016685:Mitomycin; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine